EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective
Abstract
Authors
H. Kim V. Silva D. de Oliveira D. Kashiura